Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Aspirin Krka 75 mg gastro-resistant tablets.
| Pharmaceutical Form |
|---|
|
Gastro-resistant tablet. Pink, round biconvex film-coated tablets with a diameter of about 7.2 mm. |
Each gastro-resistant tablet contains 75 mg acetylsalicylic acid.
Excipients with known effect:
Lactose monohydrate 45 mg per tablet.
Sunset yellow (E110) 0.0006 mg per tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film-coating: Talc * It may contain sodium laurilsulfate and polysorbate 80. |
Blister (PVC/Aluminium).
Pack sizes:
Blisters: 28, 30, 50, 56, 60, 84, 90 and 100 gastro-resistant tablets.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
PA1347/070/001
Date of first authorisation: 10th March 2017
Date of last renewal: 19th December 2021
| Drug | Countries | |
|---|---|---|
| ASPIRIN | Germany, Finland, Nigeria, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.